These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3962178)

  • 81. Passive immunity of premature infants against measles during early infancy.
    Ozbek S; Vural M; Tastan Y; Kahraman I; Perk Y; Ilter O
    Acta Paediatr; 1999 Nov; 88(11):1254-7. PubMed ID: 10591429
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [The antimeasles immunity in infants in the 1st year of life].
    Nikitiuk NF
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):63-5. PubMed ID: 10876898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Durability of passive measles antibody in Jamaican children.
    Christie CD; Lee-Hirsh J; Rogall B; Merrill S; Ramlal AA; Karian V; Black FL
    Int J Epidemiol; 1990 Sep; 19(3):698-702. PubMed ID: 2262267
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Measles in developing countries. Part I. Epidemiological parameters and patterns.
    McLean AR; Anderson RM
    Epidemiol Infect; 1988 Feb; 100(1):111-33. PubMed ID: 3338500
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Maternal immunity to measles and infant immunity at less than twelve months of age relative to maternal place of birth.
    Bromberg K; Shah B; Clark-Golden M; Light H; Marcellino L; Rivera M; Li PW; Erdman D; Heath J; Bellini WJ
    J Pediatr; 1994 Oct; 125(4):579-81. PubMed ID: 7931876
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cell-mediated immune responsiveness to measles. Its occurrence as a result of naturally acquired or vaccine-induced infection and in infants of immune mothers.
    Gallagher MR; Welliver R; Yamanaka T; Eisenberg B; Sun M; Ogra PL
    Am J Dis Child; 1981 Jan; 135(1):48-51. PubMed ID: 7457444
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Placental transfer of measles antibodies in Nigerian mothers.
    Adeiga A; Akinosho RO; Audu RA; Onyuewuche J; Oyewole O
    Br J Biomed Sci; 2004; 61(1):37-9. PubMed ID: 15058744
    [No Abstract]   [Full Text] [Related]  

  • 88. High measles mortality in infancy related to intensity of exposure.
    Aaby P; Bukh J; Hoff G; Leerhøy J; Lisse IM; Mordhorst CH; Pedersen IR
    J Pediatr; 1986 Jul; 109(1):40-4. PubMed ID: 3723239
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition.
    Arya SC
    Infection; 1993; 21(4):256-7. PubMed ID: 8225633
    [No Abstract]   [Full Text] [Related]  

  • 90. [Serological survey of measles in children from 5 to 15 months of age in Curitiba and São José dos Pinhais, State of Paraná, Brazil, 1983].
    Rodriguez MA; Skraba I; Maluf EP; Nazareno ER; Cavalcanti AP; de Mattos NP; Cabrine O
    Rev Saude Publica; 1984 Dec; 18(6):421-8. PubMed ID: 6536112
    [No Abstract]   [Full Text] [Related]  

  • 91. [Indices of antimeasles humoral immunity in newborn infants in relation to the anamnesis of the puerperae].
    Bolotovskiĭ VM; Zargar'iants AI; Titova NS; Chistiakova ES; Zakharova TR
    Pediatriia; 1985 Sep; (9):58-9. PubMed ID: 4080487
    [No Abstract]   [Full Text] [Related]  

  • 92. (Avid) rosette-forming cells as evidence for cellular immunity following measles virus vaccination in monkeys: correlation with the presence of haemagglutination inhibitory antibodies.
    Eghafona NO; Emejuaiwe SO
    Antiviral Res; 1990 Feb; 13(2):75-9. PubMed ID: 2344175
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antibody titers to measles, rubella, and poliomyelitis in umbilical cord serum.
    Evans HE; Millian SJ; Glass L
    Obstet Gynecol; 1973 Oct; 42(4):596-8. PubMed ID: 4742664
    [No Abstract]   [Full Text] [Related]  

  • 94. Measles vaccination in early infancy.
    Berger R; Just M; Glück R; Grassi M; Wegmann A
    Lancet; 1990 Mar; 335(8688):540. PubMed ID: 1968549
    [No Abstract]   [Full Text] [Related]  

  • 95. Assessment of two-dose vaccination schedules: availability for vaccination and catch-up strategies.
    Rouderfer V; Becker NG
    Math Biosci; 1995 Sep; 129(1):41-66. PubMed ID: 7670225
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Waning immunity and its effects on vaccination schedules.
    Rouderfer V; Becker NG; Hethcote HW
    Math Biosci; 1994 Nov; 124(1):59-82. PubMed ID: 7827424
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immunity to and infant mortality from measles.
    Coovadia HM; Kiepiela P; Wesley AG
    S Afr Med J; 1984 Jun; 65(23):918-21. PubMed ID: 6729634
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of age-specific vaccination strategies.
    Katzmann W; Dietz K
    Theor Popul Biol; 1984 Apr; 25(2):125-37. PubMed ID: 6729750
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prevalence of Maternal Measles Antibody and Its Associated Factors among Infants in Coastal Karnataka, India.
    Sathiyanarayanan S; Kumar P; Rao CR; Kumar A; Kamath A; Kamath V
    Indian J Community Med; 2020; 45(1):83-88. PubMed ID: 32029990
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Immunizing properties of live attenuated measles virus.
    DOLGIN J; LEVINE S; MARKHAM FS; CABASSO V; WEICHSEL M; RUEGSEGGER JM; COX HR
    J Pediatr; 1960 Jul; 57():36-41. PubMed ID: 13817307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.